Lifestyles: Cognitive Behavioral Therapy for Arthritis Pain and Insomnia in Older Adults

Sponsor
University of Washington (Other)
Overall Status
Completed
CT.gov ID
NCT01142349
Collaborator
Kaiser Permanente (Other)
367
2
3
55
183.5
3.3

Study Details

Study Description

Brief Summary

This study compares the efficacy of three group interventions for people with co-morbid osteoarthritis (OA) and insomnia to help them manage their OA symptoms. The investigators hypothesize that a combination cognitive-behavioral treatment will produce significantly greater initial and long-term improvements in OA symptoms than will the other two treatments.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Lifestyles A
  • Behavioral: Lifestyles B
  • Behavioral: Lifestyles C
N/A

Detailed Description

This study is only for members of the Group Health Cooperative (GHC) of Puget Sound who have both osteoarthritis pain and insomnia. The first part of the study involves filling out a mailed survey. Based on the results of the survey some respondents will be eligible for the second part of the study. Our goal in the second part is to test three different treatments for managing OA symptoms. The programs teach about things people with arthritis can do to improve the quality of their lives. All three programs deal with pain, sleep, mood and activity-but each has a slightly different focus. Participants will be randomly assigned to one of the three programs. Each program is made up of six weekly group sessions that last about 90-120 minutes. The programs will be co-led by licensed therapists and each will include 8-12 members. Study participants will also take part in a series of visits at their homes over the next 18 months. At each visit the investigators will ask them to do a few other study activities, such as keep a 7-day diary of their sleep and fill out a survey about their arthritis pain. With their permission the investigators will also ask them to let us collect some information from their GHC medical records.

Study Design

Study Type:
Interventional
Actual Enrollment :
367 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Cognitive Behavioral Therapy for Arthritis Pain and Insomnia in Older Adults
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Aug 1, 2013
Actual Study Completion Date :
Aug 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lifestyles A

Cognitive Behavioral Therapy for Pain and Insomnia

Behavioral: Lifestyles A
Six weekly group sessions that last about 90-120 minutes presenting cognitive behavioral therapy for pain and insomnia

Experimental: Lifestyle B

Cognitive Behavioral Therapy for Pain

Behavioral: Lifestyles B
Six weekly group sessions that last about 90-120 minutes presenting cognitive behavioral therapy for pain.

Active Comparator: Lifestyles C

Osteoarthritis Education

Behavioral: Lifestyles C
Six weekly group sessions that last about 90-120 minutes presenting osteoarthritis education.

Outcome Measures

Primary Outcome Measures

  1. Insomnia Severity Index (ISI) [Baseline]

    A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).

  2. Insomnia Severity Index (ISI) [Post treatment- 2 months post baseline assessment]

    A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).

  3. Insomnia Severity Index (ISI) [9 months post baseline assessment]

    A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).

  4. Insomnia Severity Index (ISI) [18 months post baseline assessment]

    A 7-item self-report screening measure that rates severity of sleep problems, interference with daily functioning, and participant distress over symptoms. Rated on a scale from 0 (no problems) to 4 (very much a problem).

  5. Global Pain Severity-Graded Chronic Pain Scale [Baseline]

    The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).

  6. Global Pain Severity-Graded Chronic Pain Scale [Post treatment-2 mos. post baseline]

    The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).

  7. Global Pain Severity-Graded Chronic Pain Scale [9 months post baseline assessment]

    The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).

  8. Global Pain Severity- Graded Chronic Pain Scale [18 months post baseline assessment]

    The Global Pain Severity Scale derived from the Graded Chronic Pain Scale consists of three 0-10 pain intensity ratings (pain right now, average pain, and worst pain in the prior month) and three 0-10 pain interference ratings (interference with daily activities, recreational, social and family activites, and ability to work including housework).

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 60+

  • Continuously enrolled in Group Health one year prior to sample pull

  • Primary care clinic at selected clinics

  • Not in "No Contact File"

  • Diagnosis 715xx (Osteoarthritis) in prior three years

Exclusion Criteria:
  • Not continuously enrolled in Group Health for at least one year

  • Medical record information indicates a diagnosis of:

  1. rheumatoid arthritis

  2. obstructive sleep apnea

  3. periodic leg movement disorder

  4. restless leg syndrome

  5. sleep-wake cycle disturbance

  6. rapid eye movement (REM) behavior disorder

  7. dementia or receiving cholinesterase inhibitors

  8. Parkinson's disease or other neurodegenerative disease known to directly impact sleep

  9. cancer in the past year and receiving chemotherapy or radiation therapy in the past year

  10. inpatient treatment for congestive heart failure within the previous 6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Group Health Research Institute Seattle Washington United States 98101
2 University of Washington Seattle Washington United States 98115

Sponsors and Collaborators

  • University of Washington
  • Kaiser Permanente

Investigators

  • Principal Investigator: Michael V Vitiello, Ph.D., University of Washington
  • Principal Investigator: Susan M McCurry, Ph.D., University of Washington
  • Principal Investigator: Michael Von Korff, Sc.D., Group Health Research Institute
  • Principal Investigator: Ben Balderson, Ph.D., Group Health Research Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Michael Vitiello, Professor, University of Washington
ClinicalTrials.gov Identifier:
NCT01142349
Other Study ID Numbers:
  • R01AG031126
  • R01AG031126
First Posted:
Jun 11, 2010
Last Update Posted:
Dec 19, 2013
Last Verified:
Dec 1, 2013

Study Results

No Results Posted as of Dec 19, 2013